Azacitidine and Soft tissue inflammation - a phase IV clinical study of FDA data

Summary:

Soft tissue inflammation is reported as a side effect among people who take Azacitidine (azacitidine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Pantoprazole, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Soft tissue inflammation when taking Azacitidine. It is created by eHealthMe based on reports of 17,184 people who have side effects when taking Azacitidine from the FDA, and is updated regularly.

What is Azacitidine?

Azacitidine has active ingredients of azacitidine. eHealthMe is studying from 17,184 Azacitidine users. Check the latest studies of Azacitidine.

What is Soft tissue inflammation?

Soft tissue inflammation is found to be associated with 175 drugs and 203 conditions by eHealthMe. Check the latest studies of Soft tissue inflammation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 17, 2026

17,184 people reported to have side effects when taking Azacitidine.
Among them, 11 people (0.06%) have Soft tissue inflammation.

Could Azacitidine cause Soft tissue inflammation?

Among these 11 people:

How long have people been on Azacitidine when they have Soft tissue inflammation? *

  • < 1 month: 57.14 %
  • 1 - 6 months: 42.86 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Soft tissue inflammation when taking Azacitidine? *

  • female: 90.91 %
  • male: 9.09 %

What is the age of people who have Soft tissue inflammation when taking Azacitidine? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Azacitidine? *

  1. Zolpidem: 7 people, 63.64%
  2. Ondansetron: 7 people, 63.64%
  3. Pantoprazole: 7 people, 63.64%
  4. Acetaminophen: 5 people, 45.45%
  5. Atorvastatin Calcium: 5 people, 45.45%
  6. Levofloxacin: 5 people, 45.45%
  7. Linezolid: 5 people, 45.45%
  8. Megestrol Acetate: 5 people, 45.45%
  9. Meropenem: 5 people, 45.45%
  10. Cefepime Hydrochloride: 5 people, 45.45%

What are other side effects people have besides Soft tissue inflammation? *

  1. Febrile Neutropenia (fever with reduced white blood cells): 8 people, 72.73%
  2. Thrombocytopenia (decrease of platelets in blood): 1 person, 9.09%
  3. Joint Effusion (presence of extra fluid in joint covering): 1 person, 9.09%
  4. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 9.09%
  5. Anaemia (lack of blood): 1 person, 9.09%
  6. Cellulitis (infection under the skin): 1 person, 9.09%
  7. Fall: 1 person, 9.09%
  8. Injection Site Inflammation: 1 person, 9.09%
  9. Muscle Oedema (accumulation of free water in muscle): 1 person, 9.09%
  10. Synovitis (inflammation of the synovial membrane): 1 person, 9.09%

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 11 people, 100.00%
  2. Infection: 7 people, 63.64%
  3. Diabetes: 7 people, 63.64%
  4. Dizziness: 7 people, 63.64%
  5. Indigestion: 7 people, 63.64%
  6. Thrombocytopenia (decrease of platelets in blood): 7 people, 63.64%
  7. Insomnia (sleeplessness): 7 people, 63.64%
  8. High Blood Cholesterol: 7 people, 63.64%
  9. Febrile Neutropenia (fever with reduced white blood cells): 5 people, 45.45%
  10. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 45.45%

* Approximation only. Some reports may have incomplete information.

Do you take Azacitidine and have Soft tissue inflammation?

- Check whether Soft tissue inflammation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azacitidine:

Soft tissue inflammation treatments and more:

How severe was Soft tissue inflammation and when was it recovered:

Expand to all the drugs that have ingredients of azacitidine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Azacitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Soft tissue inflammation:

Browse all the conditions that are associated with Soft tissue inflammation:


How the study uses the data?

The study uses data from the FDA. It is based on azacitidine (the active ingredients of Azacitidine) and Azacitidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: